Market News & Trends
XTL Biopharmaceuticals to Acquire Kitov for Up to $48 Million
XTL Biopharmaceuticals Ltd. recently announced it will acquire Kitov Pharmaceuticals Ltd. in consideration for shares as well as cash milestone payments throughout Kitov's development and…
GSK Successfully Uses Capsugel's Licaps
Capsugel recently announced that its Licaps liquid-filled hard capsules have been successfully used by major healthcare company, GlaxoSmithKline (GSK), for the most established brand in…
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films
Particle Sciences recently announced it has added new coating capabilities for preparing polymer film"based drug products from liquid formulations, under cGMPs. According to Garry Gwozdz,…
Protalix Biotherapeutics Gets $25-Million Milestone Payment
Protalix BioTherapeutics, Inc. recently announced it has received a $25-million milestone payment from Pfizer Inc. as part of the companies' global commercial agreement for ELELYSO…
Suzhou Pharma Services Announces New Offices & FDA-Approved Facility
Suzhou Pharma Services, an affiliate of Amerigen Pharmaceuticals, a new contract development and manufacturing organization specializing in solid oral dosage forms, recently announced its new…
ZIOPHARM Doses First Patient in Phase III Cancer Study
ZIOPHARM Oncology, Inc. recently announced that the first patient has been dosed in the MATISSE study (Multicenter Adaptive Trial Investigating Small cell lung cancer Survival…
Zogenix & Mallinckrodt Enter Exclusive Agreement
Zogenix Inc. and Mallinckrodt LLC recently announced an exclusive co-promotion agreement for SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System in the United States. Under terms…
6/13/2012
Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities for preparing polymer film"based drug…
6/6/2012
Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to proceed with human testing of…
Bayer HealthCare & Covance Form Strategic Partnership
Bayer HealthCare and Covance Inc. recently announced they have decided to establish a long-term strategic partnership in the area of clinical drug development, including R&D…
Catalent to Sell Commercial Packaging Operations
Catalent Pharma Solutions recently signed a definitive agreement to sell its US commercial packaging operations based in Philadelphia, PA, and Woodstock, IL, to a company…
JHP Pharmaceuticals to Produce Clinical & Commercial Supply of an Innovative Injectable
JHP Pharmaceuticals recently announced it has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and commercial supply of an innovative injectable…
New Clinical Trial Design Promises to Accelerate Approvals
The Food and Drug Administration (FDA) has drafted a regulatory guidance describing a new way of conducting breast cancer drug trials that promises to reduce…
Royer Biomedical Receives Approval to Test Polymer Delivery System
Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to proceed with human testing of AppliGel-G (Gentamicin) in management of diabetic foot ulcers (DFU).…
Scientists Restore Full Movement to Paralysed Rats
Gregoire Courtine and his team at Ecole Polytechnique Federale de Lausanne saw rats with severe paralysis walking and running again after a couple of weeks…
Royalty Pharma Raises $600 Million of Debt
Royalty Pharma recently announced it has successfully issued $600 million of incremental Term Loan B debt through RPI Finance Trust (RPIFT), bringing total debt outstanding…
Takeda's MAA Filing Triggers a $10-Million Milestone
Furiex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing…
Tranzyme Pharma & Norgine Announce Top-Line Data
Tranzyme Pharma and Norgine B.V. recently announced top-line results of the primary analysis of ULISES 008, the second of two Phase III pivotal trials evaluating…
Zurex Pharma Inc. Secures $6.2-Million Financing
Zurex Pharma, Inc. recently announced it has raised $6.2 million in Series A financing, led by Baird Venture Partners and the State of Wisconsin Investment…
5/30/2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance…
